Wallington Asset Management’s Boston Scientific BSX Stock Holding History

Wallington Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-806	Closed	-$11K	–	64
2014 Q4	$11K	Hold	806	–	–	﹤0.01%	95
2014 Q3	$10K	Hold	806	–	–	﹤0.01%	94
2014 Q2	$10K	Hold	806	–	–	﹤0.01%	92
2014 Q1	$11K	Buy	+806	New	+$10.6K	﹤0.01%	101

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Wallington Asset Management's BSX Position: Q1 2015 in Review

Wallington Asset Management sold out of Boston Scientific (BSX) in Q1 2015, closing a stake of 806 shares — an estimated $11K sold.

Wallington Asset Management first reported a position in BSX in Q1 2014 and held it in 4 quarters. The position peaked at $11K in Q4 2014. 471 funds tracked by Wall St. Rank hold BSX as of Q1 2015.

Wallington Asset Management reported no remaining Boston Scientific position as of Q1 2015 after selling out during the quarter.
Wallington Asset Management sold 806 Boston Scientific shares in Q1 2015, an estimated $11K.
Wallington Asset Management first reported a position in Boston Scientific in Q1 2014 and held it in 4 quarters.
Wallington Asset Management's Boston Scientific position peaked at $11K in Q4 2014.
471 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2015.

Based on Wallington Asset Management's 13F filing for Q1 2015, filed 15 Apr 2015.